Restoring the Bacloville trial: efficacy and harms

Clicks: 283
ID: 268665
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #33 of 124 articles by views in addiction (abingdon, england)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 124 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Restoring the Bacloville trial: efficacy and harms
Reference Key
f2020addictionrestoring Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Naudet F;Braillon A;Cristea IA;Lexchin J;;
Journal addiction (abingdon, england)
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32364248&dopt=Abstract
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine follow-up studies comment letter alcohol drinking* outpatients pmid:32364248 doi:10.1111/add.15109 florian naudet alain braillon joel lexchin baclofen* gaba-b receptor agonists

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.